Depression: symptoms, treatments and where to seek help in Morocco

01Understanding depression: a real illness, not a weakness#

Depression (medically called major depressive episode) is one of the most common psychiatric pathologies worldwide and one of the most disabling. According to the World Health Organization, it currently affects more than 280 million people on the planet, i.e. about 5% of the world's adult population, and constitutes the leading cause of disability measured in years lived with disability. This epidemiological scale makes it a major public health problem, on a par with cardiovascular diseases or cancer.

It is essential to understand from the outset that depression is a real illness, with objectifiable neurobiological bases, and not a weakness of character, a lack of willpower, or a simple "passing blues" that would resolve by "pulling oneself together". This distinction is not just academic: it conditions the management and the legitimacy of seeking care. Telling a depressed person "make an effort, you'll see, it'll get better" is as inappropriate as asking a diabetic to "make an effort" to normalise their blood glucose. Depression results from cerebral neurochemical changes (imbalances in serotonin, noradrenaline, dopamine neurotransmitters), changes in brain connectivity documented by functional MRI, genetic factors (heritability estimated at 40-50%), interacting with life events and the environment.

In Morocco, prevalence is particularly worrying. The National Survey on the Prevalence of Mental Disorders carried out by the Ministry of Health in collaboration with WHO reveals that 26.5% of Moroccan adults show depressive symptoms during their lifetime, and approximately 9% meet the criteria for a major depressive episode. These figures place Morocco among the high-prevalence countries of the MENA region, linked to several factors: rapid societal transitions, urbanisation, economic precariousness for part of the population, traumas linked to collective events (Al Haouz earthquake 2023, post-Covid economic crisis), and probably also to better detection thanks to growing awareness.

The major issue remains the cultural stigmatisation that still hinders access to care. Many patients suffer in silence, out of shame, fear of family or social judgement, or ignorance of the medical nature of their state. This stigmatisation is gradually decreasing, particularly among younger generations, but remains a real obstacle. It should be known that talking about one's depression to a general practitioner, psychiatrist, or helpline is the first step towards recovery — untreated depression is associated with considerable morbidity and mortality (suicide, cardiovascular complications, decompensation of somatic illnesses), whereas about 80% of patients correctly treated enter remission.

02Recognising the symptoms: diagnostic criteria#

The diagnosis of major depression is based on precise criteria defined by the DSM-5 (American Diagnostic Manual) and the ICD-11 (WHO classification), used in Morocco as throughout the world. These criteria avoid excessive diagnoses (not all sadness is depression) while allowing identification of true depressions that require treatment.

To establish the diagnosis of major depressive episode, at least 5 symptoms must be simultaneously present for at least 2 consecutive weeks, including at least one of the two major criteria. The first major criterion is sad, depressed or irritable mood present most of the day, almost every day, reported by the patient or observed by the entourage. Sadness is not just a passing emotion linked to an event, but a lasting state that permeates all thoughts and activities. The second major criterion is loss of interest or pleasure (anhedonia) for practically all activities, including those usually appreciated (leisure, hobbies, social relations, sexuality, food). It is this criterion that often distinguishes true depression from simple low mood — the inability to take pleasure becomes pervasive.

Beyond these major criteria, several associated criteria must be sought. Significant change in weight or appetite (loss or gain of more than 5% of weight in a month without intentional dieting). Sleep disturbances: insomnia, particularly with early morning awakening and inability to fall back asleep, or more rarely excessive hypersomnia. Psychomotor agitation or retardation observable by the entourage: sometimes anxious agitation with inability to stay still, sometimes slowing with slow gestures, monotonous voice, prostration. Almost constant fatigue or loss of energy, making the simplest tasks exhausting. A feeling of worthlessness or excessive or inappropriate guilt, with disproportionate self-criticism, feeling of being a burden to loved ones, rumination of old faults amplified in a distorted manner. A decreased ability to think, concentrate or make decisions — the "empty head", inability to read a book or follow a conversation, indecision over minor choices become disabling.

The most worrying criterion is the presence of recurrent thoughts of death, suicidal ideation with or without specific plan, or suicide attempt. These thoughts can take several forms: a desire to "no longer wake up", to "disappear", sometimes concrete plans and explicit intentions. Any mention of suicidal ideation is a medical emergency that justifies a psychiatric consultation without delay.

It must also be verified that these symptoms cause significant suffering or impact on functioning (professional, social, family), and that they are not better explained by another medical cause (hypothyroidism, early dementia, depressogenic medication, recent normal grief), psychiatric (bipolar disorder in depressive phase, schizophrenia) or by substance use (alcohol, drugs).

03The different forms of depression#

Depression is not a single entity but groups several clinical forms with sometimes different prognoses and treatments.

The classic major depressive episode is subdivided according to severity. The mild form presents 5 to 6 symptoms with moderate impact on functioning, and can often benefit from psychotherapy alone. The moderate form presents 6 to 7 symptoms with greater impact and generally benefits from the combination of psychotherapy plus medication. The severe form presents 8 symptoms or more with major impact, often with suicidal ideation, sometimes with psychotic features (delusions of guilt, ruin, hallucinations) and requires intensive management sometimes in hospital.

Dysthymia, now called persistent depressive disorder in DSM-5, is a chronic form of mild depression evolving for more than 2 years (1 year in adolescents). It is less intense than a major episode but extends over time, sometimes for decades, with a significant cumulative impact on quality of life. It can episodically worsen into a major episode on a dysthymic background ("double depression").

Postpartum depression occurs within 6 months of childbirth and affects approximately 15% of mothers in Morocco and worldwide. It should not be confused with the physiological baby blues of the first days which spontaneously regresses. Postpartum depression, deeper and more lasting, justifies specific management because it impacts the mother, the mother-child bond, and the subsequent development of the child. Systematic screening at postnatal consultations and at the paediatrician's during the first months is essential.

Bipolar disorder, formerly called manic-depressive psychosis, is characterised by alternating depressive episodes and manic or hypomanic episodes (excitement, hyperactivity, excessive spending, reduced sleep, grandiose ideas, sometimes with psychotic component). The diagnosis of bipolarity radically changes treatment: antidepressants alone can trigger manic switches, and management relies on mood stabilisers (lithium, valproate, lamotrigine) in addition to psychotherapeutic support. Any personal or family history suggestive of a manic phase must be sought in a depressed patient so as not to overlook this diagnosis.

Seasonal depression (seasonal affective disorder) regularly occurs in the same season, classically in autumn-winter with improvement in spring, and is linked to reduced light. It is more common in Nordic countries but can be observed in Morocco in the rainy North. It responds particularly well to light therapy (morning exposure to a special lamp 30 minutes per day).

Other forms exist: atypical depression (with hypersomnia, hyperphagia, leaden feeling in the limbs), catatonic depression (rare and severe), depression with melancholic features (total loss of pleasure, major anhedonia), treatment-resistant depression (failure of several well-conducted treatments).

04Causes and risk factors#

Depression results from a complex interaction between several categories of factors rather than from a single cause. This multifactorial understanding is important because it legitimises both biological approaches (medications) and psychotherapeutic approaches.

The genetic component is now well established. Twin studies conducted by Inserm and other international teams estimate the heritability of depression between 40 and 50%. Having a first-degree relative (father, mother, brother, sister, child) with depression multiplies the risk by 2 to 3. Several genes have been identified, notably polymorphisms of the serotonin transporter (5-HTTLPR), which modulate stress vulnerability.

Biologically, the neurochemical abnormalities are multiple: dysregulation of neurotransmitters (serotonin, noradrenaline, dopamine, glutamate, GABA), dysregulation of the hypothalamic-pituitary-adrenal axis with chronic hypercortisolaemia, neuroinflammation, changes in neuroplasticity (reduction in hippocampal volume observed on MRI, disruption of adult neurogenesis). These abnormalities justify the efficacy of antidepressant medications which act on these pathways.

Psychological factors include stressful life events (bereavement, separation, job loss, professional failure, serious illness), old traumas (childhood maltreatment, abuse, parental neglect — strongly associated with adult depression), dysfunctional cognitive patterns (catastrophising, ruminations, excessive self-criticism, global pessimism), personality traits (excessive perfectionism, low self-esteem, emotional dependence).

Social factors are also major: social isolation, economic precariousness, prolonged unemployment, family or marital conflicts, violence (especially domestic), discrimination. In Morocco, several specific risk factors have been identified: being a woman (risk doubled compared to men, partly for hormonal but also social reasons), being a young adult between 18 and 35 (period of multiple transitions), living in an urban setting (paradoxically, urban isolation can be more depressogenic than traditional rural community), being single or widowed, having low income, living in a precarious situation.

Several medical comorbidities are associated with increased risk: chronic illnesses (diabetes, cancer, heart disease, chronic pain, multiple sclerosis, Parkinson's), stroke, early dementia, thyroid disorders (hypothyroidism in particular). Several medications can cause or worsen depression: corticosteroids, beta-blockers in some patients, hormonal contraceptives in some women, isotretinoin for severe acne, interferon, some antiparkinsonians.

05Diagnosis and assessment with PHQ-9#

The diagnosis of depression is above all clinical, based on a thorough interview and attentive psychiatric examination by a trained doctor. No biological or imaging examination is necessary for positive diagnosis, although certain examinations may be prescribed to rule out organic causes (TSH for hypothyroidism, electrolytes, blood glucose, sometimes brain imaging in elderly subjects).

The Patient Health Questionnaire-9 (PHQ-9) is the most internationally used self-assessment tool, validated by WHO in many languages including French and Arabic. It includes 9 items corresponding to DSM-5 criteria, each rated from 0 (never) to 3 (almost every day), with a total score of 0 to 27.

The PHQ-9 is useful in several ways: initial self-screening, follow-up of evolution under treatment (reassessment every 2 to 4 weeks), early detection of relapses. Sahha offers a free and totally anonymous interactive version of the PHQ-9 on the /mind/questionnaire page, with strict respect for confidentiality — no personal data is kept.

Complete medical assessment also includes evaluation of psychiatric comorbidities (anxiety, sleep disorders, substance abuse), search for bipolar history (previous manic or hypomanic episodes), search for contextual elements (life events, bereavements, conflicts, traumas), and especially systematic suicide risk assessment by direct questions (do you have thoughts of death, urges to harm yourself, a plan?). This assessment, sometimes feared by untrained doctors, is actually well received by patients who feel understood and heard.

06Effective treatments#

The management of depression has progressed considerably in recent decades, with today a varied and effective therapeutic arsenal. The choice depends on severity, patient preferences, comorbidities, practical constraints.

For mild depression

Psychotherapy alone is generally sufficient. Cognitive-behavioural therapy (CBT) is the most scientifically validated psychotherapy, with efficacy comparable to antidepressants in mild to moderate forms and a more durable benefit in the long term. It takes place in 12 to 20 weekly 45-minute sessions, with structured work on dysfunctional thoughts, behavioural activation (gradual resumption of pleasant activities), problem solving. Other validated approaches: interpersonal psychotherapy centred on social relationships, brief psychodynamic psychotherapy, mindfulness-based cognitive therapy particularly useful for preventing relapses.

Regular physical activity has demonstrated antidepressant efficacy comparable to medications in mild to moderate depressions, according to the 2013 Cochrane meta-analysis and several subsequent studies. The recommended target is 150 minutes per week of moderate-intensity activity (brisk walking, swimming, cycling). Healthy lifestyle complements the approach: regular sleep, exposure to natural light (particularly in the morning), balanced diet, limitation of alcohol and other depressogenic substances, social activities despite the initial drop in motivation.

For moderate to severe depression

Combined antidepressant plus psychotherapy is generally recommended and more effective than each approach taken alone. Selective serotonin reuptake inhibitors (SSRIs) are the first-line medication due to their good tolerance and safety. Several molecules are available in Morocco: sertraline (Zoloft, generics), escitalopram (Sipralexa), fluoxetine (Prozac, generics), paroxetine (Deroxat, Aropax), citalopram (Seropram). The choice depends on the clinical profile, comorbidities, drug interactions.

Several important points to understand regarding antidepressants. The delay of action is 4 to 6 weeks for full antidepressant effect — do not expect improvement in the first days. Side effects often appear in the first weeks (nausea, digestive disorders, headaches, sleep disturbances, sexual disorders) and generally fade gradually. The minimum duration of treatment is 6 to 12 months after complete remission of symptoms for the first episode, to avoid relapses; for recurrent episodes, treatment may be maintained for several years or even lifelong. Sudden discontinuation of an antidepressant can cause a discontinuation syndrome (dizziness, electric sensations, anxiety) and must always be done gradually under medical supervision.

Other classes of antidepressants are available. Serotonin-noradrenaline reuptake inhibitors (SNRIs) such as venlafaxine (Effexor), duloxetine (Cymbalta), particularly useful if associated pain. Tricyclic antidepressants (amitriptyline, imipramine, clomipramine) are effective but less well tolerated (anticholinergic, cardiac effects) and reserved for failures of other classes. Mirtazapine is useful in case of insomnia or marked loss of appetite. Bupropion is interesting due to the absence of sexual effects and its effect on motivation.

For treatment-resistant depression

When two well-conducted antidepressant treatments at adequate dose have failed, this is called treatment-resistant depression. Several options exist. Electroconvulsive therapy (ECT), long caricatured and stigmatised, remains one of the most effective treatments for severe resistant depression (response rate of 70-80%). It is now performed under brief general anaesthesia, painless, with modern protocols minimising effects on memory. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive alternative developing in Morocco in several centres. Intranasal ketamine (esketamine, Spravato) is a new treatment for resistant depressions with active suicidal ideation, with very rapid effect (hours to days). Therapeutic combinations (antidepressant + lithium, antidepressant + low-dose atypical antipsychotic) are also options.

07The situation in Morocco: resources and access to care#

The depression management system in Morocco has gradually been structured but remains insufficient compared to the epidemiological needs.

The country has approximately 1,300 psychiatrists for 37 million inhabitants, i.e. 1 psychiatrist for 28,000 inhabitants, while WHO recommends at least 1 for 10,000. This density remains far below European countries (1 for 4,000-5,000 in France). The distribution is moreover very unequal, with strong concentration on the Casablanca-Rabat axis and a major deficit in rural areas and the South. Clinical psychologists are more numerous but their training and recognition remain variable.

Structurally, Morocco has approximately 30 psychiatric hospitals and psychiatric services in CHUs, the main ones being Ar-Razi Hospital in Salé (national reference, 24/7 psychiatric emergencies), Tit Mellil and Berrechid Hospital near Casablanca, CHU Ibn Rochd in Casablanca, CHU Ibn Sina in Rabat, CHU Hassan II in Fes, CHU Mohammed VI in Marrakech. These structures offer outpatient consultations, scheduled and emergency hospitalisations, specialised programmes (addictions, bipolar disorders, psychotic disorders).

Financial coverage by AMO includes public and private psychiatric consultations (reimbursement at 70% by CNSS, 80% by CNOPS), antidepressant medications listed for reimbursement, hospitalisations in psychiatric services. Outpatient psychotherapy, on the other hand, remains insufficiently covered by basic AMO in Morocco, which is one of the limitations of the system — sessions with the clinical psychologist (300-600 MAD per session) are often borne by the patient or partially covered by complementary mutuelles.

Several helplines are available free of charge and anonymously. SOS Amitié Maroc on 141 is reachable 24/7. ECOUTE Maroc on 0801-000-180 offers psychological support. Several associations offer specialised accompaniment: Sourire de Reda for young people in distress, Maman du Maroc for the perinatal period. Psychiatric teleconsultation is developing and facilitates access to care, particularly useful for patients far from major centres or having difficulty travelling.

08Suicidal ideation: what to do urgently#

Suicidal ideation is a major warning signal that should never be minimised, neither for oneself nor for a loved one. Several levels can be distinguished: passing thoughts of "no longer wanting to live", structured suicidal ideation with a scenario, clear intention with precise plan and available means. The more structured the ideation, the higher the risk.

If you yourself are gripped by suicidal ideation, several immediate actions are necessary. Do not stay alone — call a trusted relative, ask for their presence, go to someone. Remove risky means (medications, weapons, dangerous objects) — entrust them to a relative for the duration of the crisis. Immediately call a helpline (141 SOS Amitié Maroc) or psychiatric emergencies. You can also go directly to the nearest hospital emergencies (24/7 psychiatric hospitals, CHU general emergencies). Do not wait for the crisis to pass alone — immediate medical care changes the prognosis.

If a relative talks about suicidal ideation, always take it seriously, even if it seems incongruous or disproportionate to the context. Several behaviours should be adopted and others avoided. Listen without judging or minimising ("I understand that you are suffering"), ask direct questions ("have you thought about ending your life? do you have a plan?") without fear of "giving the idea" — studies show on the contrary that openly talking about suicidality reduces risk through relief and de-escalation. Do not stay alone with the person — offer to call a helpline together or accompany them to emergencies. Avoid judgements ("you have no reason to feel bad", "think of your family"), unrealistic promises ("it will be okay, I promise"), trivialisation ("you're talking nonsense"). If the situation is urgent (imminent passage to action), do not hesitate to call 141 or 15 without fearing to betray trust — life takes precedence over confidentiality in emergencies.

In Morocco, several 24/7 psychiatric emergency services are accessible: Ar-Razi Hospital in Salé (national reference), CHU psychiatric emergencies, some regional hospitals. Emergency psychiatric teleconsultation is also developing.

09Destigmatisation and hope#

Beyond the technical aspects of management, the major issue remains the destigmatisation of depression and more broadly of mental disorders in Morocco. Several messages deserve to be widely disseminated. Depression is a real illness like diabetes or hypertension, with objective neurobiological bases — not a weakness of character. It is common (1 in 5 people in a lifetime), so statistically everyone knows several affected people in their entourage. It is effectively treatable: 80% of patients correctly managed enter remission. Early diagnosis improves prognosis — the earlier one consults, the shorter the treatment and the more complete the remission. Stigmatisation is regressing in Morocco, particularly among younger generations who are more accepting of talking about their psychological difficulties.

Talking about your depression to a doctor, a psychiatrist, a trusted relative, a helpline, is the indispensable first step towards recovery. Silence is the enemy of depression — it worsens it, isolates it, chronifies it. Speech, support, adapted treatment, on the contrary open the way to a regained life, often transformed by the experience lived.